Effects of Vitamin D Supplementation on Plasma Aldosterone and ReninA Randomized Placebo-Controlled Trial: Journal of Clinical Hypertension

M.R. Grubler, M. Gaksch, K. Kienreich, N. Verheyen, J. Schmid, Bwjo Hartaigh, G. Richtig, H. Scharnagl, A. Meinitzer, B. Pieske, A. Fahrleitner-Pammer, W. Marz, A. Tomaschitz, S. Pilz

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Increasing evidence describes a possible interplay between vitamin D insufficiency with increased aldosterone. The authors sought to evaluate the effect of vitamin D supplementation on plasma aldosterone concentration (PAC) in patients with hypertension and 25-hydroxyvitamin D[25(OH)D] insufficiency. The Styrian Vitamin D Hypertension Trial was a single-center, double-blind, placebo-controlled randomized clinical trial conducted from 2011 to 2014. Two hundred patients with arterial hypertension and 25(OH)D levels
Original languageEnglish
Pages (from-to)608-613
Number of pages6
JournalJournal of Clinical Hypertension
Volume18
DOIs
Publication statusPublished - 2016

Cite this